Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03506360 · OUTCOME

PDL-1 Expression on Myeloma Cells and Non-tumor Cell Compartments From the Bone Marrow

Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · Source last updated 2024-01-09

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Baseline

What was measured

Each measure will be summarized descriptively by median, minimum (min), maximum (max) and interquartile range.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Each measure will be summarized descriptively by median, minimum (min), maximum (max) and interquartile range.
reporting Status
NOT_POSTED
time Frame
Baseline
title
PDL-1 Expression on Myeloma Cells and Non-tumor Cell Compartments From the Bone Marrow
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice